KYMR Insider Transactions — Page 11
1,189 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1,001–1,100; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Biotechnology Value Trading Fund OS LP | DirectorOther | 2022-05-05 | Purchase | 75,495.0 | $19.6 |
| BVF Partners OS Ltd. | DirectorOther | 2022-05-05 | Purchase | 75,495.0 | $19.6 |
| BVF I GP LLC | DirectorOther | 2022-05-05 | Purchase | 75,495.0 | $19.6 |
| BVF II GP LLC | DirectorOther | 2022-05-05 | Purchase | 75,495.0 | $19.6 |
| BVF GP HOLDINGS LLC | DirectorOther | 2022-05-05 | Purchase | 75,495.0 | $19.6 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2022-01-31 | Purchase | 14,323.0 | $40.7 |
| BVF PARTNERS L P/IL | DirectorOther | 2022-01-31 | Purchase | 14,323.0 | $40.7 |
| BVF INC/IL | Other | 2022-01-31 | Purchase | 14,323.0 | $40.7 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2022-01-31 | Purchase | 14,323.0 | $40.7 |
| LAMPERT MARK N | Other | 2022-01-31 | Purchase | 14,323.0 | $40.7 |
| Biotechnology Value Trading Fund OS LP | Other | 2022-01-31 | Purchase | 14,323.0 | $40.7 |
| BVF Partners OS Ltd. | Other | 2022-01-31 | Purchase | 14,323.0 | $40.7 |
| BVF I GP LLC | Other | 2022-01-31 | Purchase | 14,323.0 | $40.7 |
| BVF II GP LLC | Other | 2022-01-31 | Purchase | 14,323.0 | $40.7 |
| BVF GP HOLDINGS LLC | Other | 2022-01-31 | Purchase | 14,323.0 | $40.7 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2022-01-31 | Purchase | 20,085.0 | $40.7 |
| BVF PARTNERS L P/IL | DirectorOther | 2022-01-31 | Purchase | 20,085.0 | $40.7 |
| BVF INC/IL | Other | 2022-01-31 | Purchase | 20,085.0 | $40.7 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2022-01-31 | Purchase | 20,085.0 | $40.7 |
| LAMPERT MARK N | Other | 2022-01-31 | Purchase | 20,085.0 | $40.7 |
| Biotechnology Value Trading Fund OS LP | Other | 2022-01-31 | Purchase | 20,085.0 | $40.7 |
| BVF Partners OS Ltd. | Other | 2022-01-31 | Purchase | 20,085.0 | $40.7 |
| BVF I GP LLC | Other | 2022-01-31 | Purchase | 20,085.0 | $40.7 |
| BVF II GP LLC | Other | 2022-01-31 | Purchase | 20,085.0 | $40.7 |
| BVF GP HOLDINGS LLC | Other | 2022-01-31 | Purchase | 20,085.0 | $40.7 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2022-01-27 | Purchase | 37,859.0 | $38.33 |
| BVF PARTNERS L P/IL | DirectorOther | 2022-01-27 | Purchase | 37,859.0 | $38.33 |
| BVF INC/IL | Other | 2022-01-27 | Purchase | 37,859.0 | $38.33 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2022-01-27 | Purchase | 37,859.0 | $38.33 |
| LAMPERT MARK N | Other | 2022-01-27 | Purchase | 37,859.0 | $38.33 |
| Biotechnology Value Trading Fund OS LP | Other | 2022-01-27 | Purchase | 37,859.0 | $38.33 |
| BVF Partners OS Ltd. | Other | 2022-01-27 | Purchase | 37,859.0 | $38.33 |
| BVF I GP LLC | Other | 2022-01-27 | Purchase | 37,859.0 | $38.33 |
| BVF II GP LLC | Other | 2022-01-27 | Purchase | 37,859.0 | $38.33 |
| BVF GP HOLDINGS LLC | Other | 2022-01-27 | Purchase | 37,859.0 | $38.33 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2022-01-27 | Purchase | 58,042.0 | $38.33 |
| BVF PARTNERS L P/IL | DirectorOther | 2022-01-27 | Purchase | 58,042.0 | $38.33 |
| BVF INC/IL | Other | 2022-01-27 | Purchase | 58,042.0 | $38.33 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2022-01-27 | Purchase | 58,042.0 | $38.33 |
| LAMPERT MARK N | Other | 2022-01-27 | Purchase | 58,042.0 | $38.33 |
| Biotechnology Value Trading Fund OS LP | Other | 2022-01-27 | Purchase | 58,042.0 | $38.33 |
| BVF Partners OS Ltd. | Other | 2022-01-27 | Purchase | 58,042.0 | $38.33 |
| BVF I GP LLC | Other | 2022-01-27 | Purchase | 58,042.0 | $38.33 |
| BVF II GP LLC | Other | 2022-01-27 | Purchase | 58,042.0 | $38.33 |
| BVF GP HOLDINGS LLC | Other | 2022-01-27 | Purchase | 58,042.0 | $38.33 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2022-01-24 | Purchase | 114,726.0 | $37.76 |
| BVF PARTNERS L P/IL | DirectorOther | 2022-01-24 | Purchase | 114,726.0 | $37.76 |
| BVF INC/IL | Other | 2022-01-24 | Purchase | 114,726.0 | $37.76 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2022-01-24 | Purchase | 114,726.0 | $37.76 |
| LAMPERT MARK N | Other | 2022-01-24 | Purchase | 114,726.0 | $37.76 |
| Biotechnology Value Trading Fund OS LP | Other | 2022-01-24 | Purchase | 114,726.0 | $37.76 |
| BVF Partners OS Ltd. | Other | 2022-01-24 | Purchase | 114,726.0 | $37.76 |
| BVF I GP LLC | Other | 2022-01-24 | Purchase | 114,726.0 | $37.76 |
| BVF II GP LLC | Other | 2022-01-24 | Purchase | 114,726.0 | $37.76 |
| BVF GP HOLDINGS LLC | Other | 2022-01-24 | Purchase | 114,726.0 | $37.76 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2022-01-24 | Purchase | 158,041.0 | $37.76 |
| BVF PARTNERS L P/IL | DirectorOther | 2022-01-24 | Purchase | 158,041.0 | $37.76 |
| BVF INC/IL | Other | 2022-01-24 | Purchase | 158,041.0 | $37.76 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2022-01-24 | Purchase | 158,041.0 | $37.76 |
| LAMPERT MARK N | Other | 2022-01-24 | Purchase | 158,041.0 | $37.76 |
| Biotechnology Value Trading Fund OS LP | Other | 2022-01-24 | Purchase | 158,041.0 | $37.76 |
| BVF Partners OS Ltd. | Other | 2022-01-24 | Purchase | 158,041.0 | $37.76 |
| BVF I GP LLC | Other | 2022-01-24 | Purchase | 158,041.0 | $37.76 |
| BVF II GP LLC | Other | 2022-01-24 | Purchase | 158,041.0 | $37.76 |
| BVF GP HOLDINGS LLC | Other | 2022-01-24 | Purchase | 158,041.0 | $37.76 |
| Jacobs Bruce N. | Chief Financial Officer | 2022-01-12 | Sale | 1,422.0 | $53.27 |
| Jacobs Bruce N. | Chief Financial Officer | 2022-01-12 | Sale | 7,151.0 | $52.13 |
| Jacobs Bruce N. | Chief Financial Officer | 2022-01-12 | Sale | 6,427.0 | $51.21 |
| Mainolfi Nello | Chief Executive Officer | 2022-01-12 | Sale | 241.0 | $53.97 |
| Mainolfi Nello | Chief Executive Officer | 2022-01-12 | Sale | 1,623.0 | $53.27 |
| Mainolfi Nello | Chief Executive Officer | 2022-01-12 | Sale | 4,022.0 | $52.02 |
| Mainolfi Nello | Chief Executive Officer | 2022-01-12 | Sale | 2,726.0 | $51.31 |
| Mainolfi Nello | Chief Executive Officer | 2022-01-11 | Sale | 347.0 | $55.05 |
| Mainolfi Nello | Chief Executive Officer | 2022-01-11 | Sale | 6,644.0 | $54.42 |
| Mainolfi Nello | Chief Executive Officer | 2022-01-11 | Sale | 9,932.0 | $53.68 |
| Mainolfi Nello | Chief Executive Officer | 2022-01-10 | Sale | 106.0 | $54.99 |
| Mainolfi Nello | Chief Executive Officer | 2022-01-10 | Sale | 4,201.0 | $54.4 |
| Mainolfi Nello | Chief Executive Officer | 2022-01-10 | Sale | 10,673.0 | $53.35 |
| Mainolfi Nello | Chief Executive Officer | 2022-01-10 | Sale | 7,485.0 | $52.46 |
| Jacobs Bruce N. | Chief Financial Officer | 2021-12-03 | Sale | 300.0 | $55.07 |
| Jacobs Bruce N. | Chief Financial Officer | 2021-12-03 | Sale | 1,987.0 | $54.32 |
| Jacobs Bruce N. | Chief Financial Officer | 2021-12-03 | Sale | 7,713.0 | $53.31 |
| Gollob Jared | Chief Medical Officer | 2021-11-02 | Sale | 1,202.0 | $64.34 |
| Gollob Jared | Chief Medical Officer | 2021-11-02 | Sale | 5,280.0 | $63.5 |
| Gollob Jared | Chief Medical Officer | 2021-11-02 | Sale | 8,514.0 | $62.89 |
| Gollob Jared | Chief Medical Officer | 2021-11-01 | Sale | 4,065.0 | $63.17 |
| Gollob Jared | Chief Medical Officer | 2021-11-01 | Sale | 15,911.0 | $62.34 |
| Gollob Jared | Chief Medical Officer | 2021-11-01 | Sale | 15,134.0 | $61.5 |
| Gollob Jared | Chief Medical Officer | 2021-11-01 | Sale | 7,387.0 | $60.4 |
| Mainolfi Nello | Chief Executive Officer | 2021-10-11 | Sale | 744.0 | $54.5 |
| Mainolfi Nello | Chief Executive Officer | 2021-10-11 | Sale | 5,712.0 | $53.58 |
| Mainolfi Nello | Chief Executive Officer | 2021-10-08 | Sale | 271.0 | $61.87 |
| Mainolfi Nello | Chief Executive Officer | 2021-10-08 | Sale | 670.0 | $60.32 |
| Mainolfi Nello | Chief Executive Officer | 2021-10-08 | Sale | 7,920.0 | $59.28 |
| Mainolfi Nello | Chief Executive Officer | 2021-10-08 | Sale | 2,078.0 | $57.29 |
| Mainolfi Nello | Chief Executive Officer | 2021-10-08 | Sale | 9,369.0 | $56.82 |
| Mainolfi Nello | Chief Executive Officer | 2021-10-08 | Sale | 21,236.0 | $55.56 |
| Jacobs Bruce N. | Chief Financial Officer | 2021-09-03 | Sale | 1,500.0 | $60.5 |
| Jacobs Bruce N. | Chief Financial Officer | 2021-09-03 | Sale | 8,500.0 | $60.05 |
| Chesworth Richard | Chief Scientific Officer | 2021-08-27 | Sale | 33,779.0 | $60.12 |